Answers are grounded in this paper and cite their sources.
The case of a young female patient with chronic active hepatitis B, vasculitic purpura, edema, and circulating immune complexes due to mixed Cryoglobulinemia is described. Serum transami‐nases were elevated. Serological assays showed hepatitis B surface antigen (HBsAg), antibody to hepatitis B e antigen (anti‐HBe), and antibody to hepatitis B core antigen (anti‐HBc) antibodies but no antibody to hepatitis C virus (anti‐HCV) or antibody to hepatitis delta virus (anti‐HDV) antibodies. Using hepatitis B virus‐polymerase chain reaction (HBV‐PCR) and direct sequencing a precore/core (preC/C) mutant unable to synthesize HBeAg was detected in serum. HBV antigens were demonstrated in the circulating immune complexes. Following 1 month of treatment with interferon‐a 2b 3 miu three times weekly, alanine aminotransferases returned to normal levels while cryoglobulins and immune complexes disappeared from serum. In addition, 2 months after the onset of treatment serum HBV‐DNA was no longer detectable by PCR. Prior to treatment the analysis of cellular immune reactions of peripheral blood mononu‐clear cells showed a major proliferative response to HBcAg, preS1Ag and HBxAg and a minor response to HBeAg and HBsAg. One month after conclusion of treatment a decline in T‐cell reactivity against all HBV antigens was observed. During clinical response to the therapy, however, a strong proliferative response of T cells to HBcAg and HBeAg was demonstrated. In conclusion, immune complex disease may complicate chronic hepatitis B in patients expressing HBe‐minus HBV mutants. Treatment with interferon‐a was found to be effective in mixed Cryoglobulinemia even in the presence of HBe‐minus HBV mutants. Antiviral effects of interferon‐a induce a decrease in specific T‐cell recognition of HBV antigens. Clinical response and virus elimination were, however, accompanied by a reconstitution of cellular immune responses to HBV core antigens, i.e., HBcAg and HBeAg. The response to certain T cell epitopes on these antigens may be of pathogenetic relevance for virus elimination.
No takes yet. Share an insight, caveat, or question.
Löhr et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: